← FDA Drug Approvals (Drugs@FDA)
RIFAMPIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON PHARMS TEVA · Approved 2016-01-19
Drug application
- FDA Application #
ANDA206736- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RIFAMPIN
- Generic name
- Rifampin
- Active ingredients
- RIFAMPIN
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- WATSON PHARMS TEVA
- First approval
- 2016-01-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown